Thailand’s Ministry of Public Health will seek approval, from the immune enhancement against diseases subcommittee, for the Disease Control Department to use a combined AstraZeneca and Pfizer COVID-19 vaccine regimen for Thai people.
Disease Control Department Director-General Dr. Opart Karnkawinpong said today (Thursday) that the regimen is in the department’s vaccination plan, but not put on trial yet.
Mix-and-match vaccination regimens are now widely used in Thailand, with Sinovac jabs followed by an AstraZeneca dose being administered to the general public, and Pfizer as the third jab for many frontline medics.
According to the Ministry of Higher Education, Science, Research and Innovation’s report about vaccinations in Thailand up to October 6th, 33,505,887 first doses have been given, accounting for 50.6% of Thailand’s population, 21,595,916 second doses (32.6%) and 1,554,444 third doses (2.3%).
Bangkok has the highest vaccination ras, with 101% getting first jabs, 54.8% second jabs and 4.8% their third jab.
In the provinces, Pathum Thani, 64.3%, 45.4% and 1.5% for first, second and third jabs respectively; Samut Prakan, 67.3%, 42.7% and 1.9% as first, second and third jabs; Samut Sakhon, 64%, 42.8% and 4.5% for first, second and third jabs; Nonthaburi, 51.5%, 41.2% and 4% for first, second and third jabs; and Nakhon Pathom, 42.1%, 29.8% and 1.9% for first, second and third jabs respectively.
Meanwhile, the COVID-19 Information Centre reported 11,200 new COVID-19 cases today, including 11,042 locally acquired cases, 138 among prisoners and 20 cases among foreign arrivals.
10,087 people have recovered today and death toll was 113.
